TY  - JOUR
AU  - Voss, Ralf-Holger
AU  - Echchannaoui, Hakim
AU  - Huang, He
AU  - Xue, Shao-An
TI  - Editorial: Translation of genetically engineered T cells in cancer immunotherapy.
JO  - Frontiers in immunology
VL  - 14
SN  - 1664-3224
CY  - Lausanne
PB  - Frontiers Media
M1  - DKFZ-2023-01931
SP  - 1278677
PY  - 2023
KW  - CAR toxicity (Other)
KW  - CAR-T (Other)
KW  - TCR-T (Other)
KW  - cancer immunotherapy (Other)
KW  - genetic/cellular engineering (Other)
KW  - genome editing (Other)
KW  - immunosuppression (Other)
KW  - tumor specific/associated antigens (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:37744369
C2  - pmc:PMC10513460
DO  - DOI:10.3389/fimmu.2023.1278677
UR  - https://inrepo02.dkfz.de/record/283145
ER  -